Answers are grounded in this paper and cite their sources.
This exploratory study reveals how 11β-HSDs influence glucocorticoid action in the brain, indicating potential therapeutic targets.
Clearly the actions of 11beta-HSDs in the CNS are only beginning to be unraveled, though some principles are emerging. 11Beta-hydroxysteroid dehydrogenase type 2 inactivates glucocorticoids but is found only in a few very restricted sites in the adult brain. Its role in the fetal CNS is likely to be more extensive, but is largely unexplored. 11Beta-hydroxysteroid dehydrogenase type 1 is a reductase in CNS cells and amplifies glucocorticoid action. The striking protection against cognitive decline seen in elderly 11beta-HSD1 knockout mice suggest that manipulation of this isozyme may be a useful therapeutic avenue to explore.
No takes yet. Share an insight, caveat, or question.
Seckl et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: